Third Line Antiretroviral Optimization (THILAO) for HIV-1 infected subjects presenting with virologic failure
Principal Investigator: Moussa Seydi
ANRS 1226



Hepatitis C Treatment in Africa: Feasibility, tolerance and efficacy of interferon-free, antiviral treatment with sofosbuvir and ribavirin for the treatment of genotype 1,2 and 4 hepatitis C virus-infected patients in West

and Central Africa.
Principal Investigator: Moussa Seydi

ANRS 12311


Ebola vaccine adult study (EBOLA Z CHAD3-005 - 202091)
Principal Investigator: Moussa Seydi

Ebola vaccine pediatric study (EBOLA Z CHAD3-005 - 202091)
Principal Investigator: Moussa Seydi



Programmatic approaches to screening, prophylaxis and treatment of tuberculosis
Co-Investigator: Moussa Seydi
AI69924 NIH 
2014-2015


Nutritional support to improve adherence and treatment completion among HIV-Tuberculosis co-infected adults in Senegal, West Africa: An implementation study                  
Principal Investigator: Noelle Benzekri
Firland Foundation Clinical Research Pilot Grant
2015-2017



Traditional healers and HIV outcomes in Senegal, West Africa
Principal Investigator: Noelle Benzekri
Ongoing


An evaluation of infectious disease hospital admissions in urban and rural Senegal
Principal Investigator: Noelle Benzekri
Ongoing


HIV, malnutrition, and food insecurity in Senegal: A longitudinal study to identify high-impact interventions
Principal Investigator: Noelle Benzekri
NIH-NIAID - K23

Ongoing​


Parasitic co-infections among PLHIV in Senegal 
Principal Investigator: Noelle Benzekri

Ongoing


HIV and the dual burden of malnutrition in Senegal: A retrospective study
Principal Investigator: Noelle Benzekri
2015-2017

CFAR International Pilot Award: HIV, malnutrition, and food insecurity in Senegal: A pilot study
Principal Investigator: Noelle Benzekri
2014-2016
NIH - P30-AI027757 



Cohort Study of Injectable Drugs Users in Senegal (CoDISEN) incorporating a strategy of "Test and Treat" for HIV
Principal Investigator: Moussa Seydi
ANRS 12334
2015-2017

Antiretroviral treatment and HIV-HBV co-infection                                          Co-Investigator: Moussa Seydi
NIH (IeDEA West Africa- F. Dabis)    
2014-2016


Prevalence and determinants of hepatitis B, hepatitis C, and hepatic fibrosis in prisons
Principal Investigator: Moussa Seydi

HBV Cohort (MOBSEN)                                                                                       Principal Investigator: Moussa Seydi
ANRS 12231
2015-2016

Prevalence of hepatitis B viremia in HIV/HBV co-infected patients on ART Principal Investigator: Moussa Seydi
ANRS12221/12169


Molecular Epidemiology of HIV/HBV and HIV/HCV Co-infection in Senegal, West Africa
Principal Investigator: Robert Smith
Puget Sound PGH Pilot Fund Awards
2008-2009



HPV-16 Viral Loads associated with HIV and Cervical Cancer in Senegal
Principal Investigator: Stephen Hawes
2009-2010
CFAR HIV-Associated Malignancy Pilot Award


Clinical Trial to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biological’s HPV vaccine
2007-2009
GlaxoSmithKline (GSK), Clinical Study: 106069 (HPV-021)



​Epidemiology & Biology of HIV positive and HIV negative Cervical Neoplasia
Principal Investigator: Nancy Kiviat
1997-2002
NIH/NCI  R01 CA75920


Epidemiology of HIV-1 and HIV-2 in the Cervix and Vagina
Principal Investigator: Nancy Kiviat
1997-1999
NIH/NIAID R01 AI37466 


Natural History of Cervical Neoplasia in HIV-1 and HIV-2
Principal Investigator: Nancy Kiviat
1994-1999
NIH/NCI  R01 CA62801 

Cervical Neoplasia and HIV Infection in Senegal
Principal Investigator: Nancy Kiviat
1990-1994
NIH/NCI  R01 CA50856



An Open Label Trial of STRIBILD™ (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) for ARV-naïve HIV-2 Infected Adults in Dakar, Senegal
Principal Investigator: Geoffrey Gottlieb
2013-2015
IN-US 236-0142 - Gilead Sciences, Inc.


A Demonstration Project of HIV Pre-Exposure Prophylaxis (PrEP) with Tenofovir/Emtricitabine (TDF/FTC) Among Female Sex Workers in Dakar, Senegal.

Co-investigators: Geoffrey Gottlieb and Stephen Hawes
2014-2016

OPP1084414 - Bill & Melinda Gates Foundation 


International Epidemiologic Databases to Evaluate AIDS (IeDEA) - West Africa Collaboration
Principal Investigator: Francois Dabis    
Co-investigators: Moussa Seydi and Geoffrey Gottlieb
2011-2020
2U01AI069919-06 - NIH



Improving Diagnosis, Treatment & Detection of Drug Resistance in HIV-2 Infection
Principal Investigator: Geoffrey Gottlieb
2015-2020
R01 AI120765 - NIH


Antiretroviral Therapy for HIV-2 Infection in Senegal
Principal Investigator: Geoffrey Gottlieb
2005-2015
NIH/NIAID - 2R01 AI060466 


Novel Inhibitors for Antiretroviral Therapy of HIV-2
Principal Investigator: Geoffrey Gottlieb
Royalty Research Fund - A92723
2014-2015

Susceptibility of HIV-2 to HIV-1 Integrase Inhibitors and CCR5 Co-receptor Antagonists
Principal Investigator: Geoffrey Gottlieb
Royalty Research Fund - 4504​
2009-2010

Pilot Study of Antiretroviral Therapy for HIV-1/HIV-2 Dual Infection in Senegal, West Africa
Principal Investigator: Geoffrey Gottlieb
2008-2010
Puget Sound PGH Pilot Fund Awards 

Epidemiology of HIV-1/HIV-2 Dual Infection
Principal Investigator: Geoffrey Gottlieb
2001-2006
NIH/NIAID - K08 AI049755

Control of HIV-1 by HIV-2 Associated Immune Responses
Principal Investigator: Nancy Kiviat
2000-2006
NIH/NIAID R01 AI48470 



Integrated Bio-Social Models for HIV Epidemiology
Co-investigator: Geoffrey Gottlieb
2014-2019
1R01 AI108490-A1 - NIH


Lentiviral Resistance to Tetherin

Co-investigator: Geoffrey Gottlieb
2012-2017
1R01 AI098485-01A1 - NIH


Occurrence and Outcome of Dual HIV-1 Infection
Co-investigator: Geoffrey Gottlieb
2000-2015
2R37 AI047734-06A1 - NIH



UW-Alere POC testing of HIV-2 viral load
2014-2015

Alere, Inc.


Senegal training for HIV viral load testing on the Abbott m2000 platform
2012-2014

UW/FHCRC Center for AIDS Research Infrastructure Award



Chlamydia & Aberrant DNA Methylation in Cervical Cancer
Principal Investigator: Nancy Kiviat
2006-2011
NIH/NCI - R01 CA 115713

HIV-associated DNA Hypermethylation in Cervical Cancer
Principal Investigator: Nancy Kiviat
2005-2010
NIH/NCI - R01 CA111187


Developing New Approaches for Cervical Cancer Control
Principal Investigator: Nancy Kiviat
2002-2007
NIH/NCI R01 CA097275 


Breast Cancer in Senegal - Part of Biomarkers Development Laboratory (BDL) of Early Detection Research Network (EDRN)
Principal Investigator: Nancy Kiviat
2000-2005
NIH 5U01 CA085050


CFAR International Pilot Award: HIV and the Oral Microbiome in ART-Naïve Adults in Dakar, Senegal
Principal Investigator: Mary Campbell
2012
NIH - P30-AI027757

Epidemiology of Oral HIV 1 & 2 Infection in High Risk Women
Principal Investigator: Critchlow and Stephen Hawes
1999-2004
NIH/NIDCR R01 DE12925 

Early Onset Periodontitis
Principal Investigator: Critchlow
1999-2002
NIH/NIDCR P60 DE13061 


Epidemiology of HIV-1 and HIV-2 Associated Oral Disease 
Principal Investigator: Critchlow
1994-1999
NIH/NIAID R01 DE11372

THE UNIVERSITY OF WASHINGTON-SENEGAL

RESEARCH COLLABORATION